Marie Lindner
Directeur/Bestuurslid bij Giiant Pharma, Inc.
Oorsprong van het eerstegraads netwerk van Marie Lindner
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 19 | |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona.
15
| Holding Company | Investment Managers | 15 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
BioCurate Pty Ltd.
6
| Private Company | 6 | |
Giiant Pharma, Inc.
 Giiant Pharma, Inc. BiotechnologyHealth Technology Giiant Pharma, Inc. is a Canadian preclinical-stage biotech company that specializes in designing gut-restricted small molecule drug therapeutics with various biological targets in gastroenterology. The company is based in Montréal, Canada and was founded by Elizabeth Elizabeth Kwong. The company's proprietary precision delivery technology platform allows for the creation of tissue-specific drugs with improved tolerability and enhanced therapeutic effects. Giiant's first lead program, GT-2108, is a microbiota-activated PDE4 inhibitor prodrug. Maxime Ranger has been the CEO of the company since 2021.
6
| Holding Company | Biotechnology | 6 |
The Biotechnology Greenhouse Corp. of Southeastern PA
 The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance The Biotechnology Greenhouse Corp. of Southeastern PA (BioAdvance) is a venture capital firm founded in 2002. The firm is headquartered in Philadelphia, Pennsylvania.
5
| Private Company | Investment Managers | 5 |
Elan Drug Delivery, Inc.
 Elan Drug Delivery, Inc. Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Elan Drug Delivery, Inc. is engaged in manufacturing, fabricating, or processing drugs in pharmaceutical preparations for human or veterinary use. The company is based in King Of Prussia, PA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Orthogon Therapeutics LLC
 Orthogon Therapeutics LLC Pharmaceuticals: MajorHealth Technology Orthogon Therapeutics LLC is a privately held R&D firm that specializes in drug discovery and development. The company is based in Canton, MA. The company is headquartered in the biotech hub of Greater Boston and has a branch in Leuven. Orthogon uses an innovative structure-based and biophysics platform to design novel medicines. The company's portfolio of infectious disease assets includes antiviral therapeutics, with a lead program being a first-in-class, orally administrable small molecule inhibitor of BK virus replication. Orthogon has secured over $12.50m in investment to date and has additional discovery programs, including a treatment for antibiotic-resistant bacterial infections. The company was founded by Ali Munawar, a veteran biotech entrepreneur, and experienced drug discovery scientists with a mission to prolong and improve patient quality of life.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Marie Lindner via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Cutanea Life Sciences, Inc.
 Cutanea Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Cutanea Life Sciences, Inc. Develops and commercialises innovative dermatology related products. The company was founded in May 2005 and is headquartered in Wayne, PA. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Masters Business Admin Graduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin | |
Dermik Laboratories, Inc.
 Dermik Laboratories, Inc. Household/Personal CareConsumer Non-Durables Dermik Laboratories, Inc. manufactures health and skin care products. Its products and services include acne, actinic keratosis, nail fungus, dermatitis and eczema, and chemical peels treatment. The company was founded in 1947 and is located in Berwyn, PA. | Household/Personal Care | President Corporate Officer/Principal General Counsel Corporate Officer/Principal Public Communications Contact | |
Inamed Corp.
 Inamed Corp. Medical SpecialtiesHealth Technology Inamed Corp. developed and manufactured breast implants, wrinkle prevention & obesity solutions. Its products were available through its two business divisions: INAMED Aesthetics, and INAMED Health. The company offered breast implants for augmentation, reconstruction surgeries, invasive surgeries for sustained weight loss and other dermal products to correct facial wrinkles. INAMED was headquartered in Santa Barbara, CA. | Medical Specialties | Director/Board Member Sales & Marketing Chief Executive Officer Corporate Officer/Principal | |
Isolagen Technologies, Inc.
 Isolagen Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Isolagen Technologies, Inc. researches and develops cellular technology. specializes in the development and commercialization of autologous cellular system. The company is headquartered in Houston, TX. | Miscellaneous Commercial Services | Director of Finance/CFO Chief Executive Officer Chief Executive Officer | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| PHIO PHARMACEUTICALS CORP. | Biotechnology | Chief Executive Officer General Counsel Corporate Officer/Principal | |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Ursinus College | College/University | Director/Board Member Undergraduate Degree | |
| University of the Sciences in Philadelphia | College/University | Director/Board Member Director/Board Member | |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | Private Equity Investor Private Equity Investor | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | President Corporate Officer/Principal | |
Inversago Pharma, Inc.
 Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| Weizmann Institute of Science | College/University | Graduate Degree Doctorate Degree | |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Glixogen Therapeutics Ltd.
 Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Villanova University | College/University | Graduate Degree Undergraduate Degree | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Protekt Therapeutics Ltd.
 Protekt Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Protekt Therapeutics Ltd. operates as a biopharmaceutical company. The firm develop a drug for enhancing the long-term memory of those suffering from mild cognitive impairment. The company is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Quaker Partners Management LP
 Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Director/Board Member Private Equity Investor | |
| Thomas Jefferson University | College/University | President President | |
Suneva Medical, Inc.
 Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Suneva Medical, Inc. develops, manufactures and commercializes novel, differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets. It offers ArteFill, ReFissa, Bellafill, and ReGenica Skincare products. The company is headquartered in San Diego, CA. | Electronic Equipment/Instruments | Sales & Marketing Chief Executive Officer | |
| Rutgers State University of New Jersey | College/University | Graduate Degree Corporate Officer/Principal | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Chief Executive Officer | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Comptroller/Controller/Auditor President | |
Genesys Capital Partners, Inc.
 Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor Private Equity Investor | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Private Equity Analyst | |
| Philadelphia University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Toronto | College/University | Masters Business Admin Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree | |
| University of Massachusetts | College/University | Graduate Degree Director/Board Member | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Universität Konstanz | College/University | Doctorate Degree | |
Amarna Therapeutics BV
 Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Medical/Nursing Services | Director/Board Member | |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Rockefeller University | College/University | Corporate Officer/Principal | |
| ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
BioMedx Group, Inc.
 BioMedx Group, Inc. Medical SpecialtiesHealth Technology BioMedx Group, Inc. operates as a medical technology company transforming the cosmetic surgery consultation services. The firm engages in product development focus on the modeling and simulation of the human face for aesthetic and facial reconstruction applications. The company was founded by Rudy A. Mazzocchi and is headquartered in Baltimore, MD. | Medical Specialties | Director/Board Member | |
| REDX PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
OMEICOS Therapeutics GmbH
 OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Biotechnology | Chairman |
Statistieken
Internationaal
| Verenigde Staten | 27 |
| Israël | 12 |
| Canada | 5 |
| Duitsland | 5 |
| Verenigd Koninkrijk | 3 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 17 |
| Commercial Services | 6 |
| Finance | 4 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 234 |
| Corporate Officer/Principal | 115 |
| Chairman | 54 |
| Chief Executive Officer | 54 |
| President | 47 |
Sterkste connecties
| Insiders | |
|---|---|
| Argeris Karabelas | 42 |
| Erez Chimovits | 30 |
| Ivan Philip Gergel | 24 |
| Jean-François Pariseau | 24 |
| Frank Baldino | 23 |
| George Poste | 21 |
| Martin Schmieg | 20 |
| Robert Barchi | 18 |
| Zeev Zehavi | 18 |
| Bernhard Kirschbaum | 15 |
| James Anthony Ermilio | 15 |
| Michael Gilman | 14 |
| Anne Phillips | 14 |
| Jamie Stiff | 13 |
| Charles Huiner | 13 |
- Beurs
- Insiders
- Marie Lindner
- Bedrijfsconnecties
